Effectiveness of Escitalopram on cognitive performance in patients after ischemic stroke.
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group receive 10 mg of escitalopram for 3 months in addition to standard stroke treatment, one month after ischemic stroke. Intervention 2: Control
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Ischemic stroke based on CT scan and MRI findings Full consciousness ability to speak
Exclusion criteria
Exclusion criteria: Old brain parenchymal lesions Evidence of a history of cognitive impairment and dementia prior to stroke Obvious thyroid disorders History of recent use of SSRIs, MAO inhibitors, TCAs, SNRIs History of serious side effects after taking SSRIs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive performance status before and after intervention based on the MOCA questionnaire. Timepoint: Before the intervention begins and after it ends. Method of measurement: MOCA questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Checking the level of depression. Timepoint: Before the intervention begins and after it ends. Method of measurement: Hamilton Depression Inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeed Kazemi Roudsari
Hamedan University of Medical Sciences
Outcome results
None listed